There are now over a dozen FDA-approved medications certified for treating pulmonary hypertension. Working through three major pathways to target the underlying pathology, the medications have been shown to improve outcome in patients with pulmonary hypertension. In addition, surgical intervention in select cases, such as chronic thromboembolic pulmonary hypertension (CTEPH), can be curative.
Research opportunities
WVU’s current research efforts are targeted towards understanding the relationship of pulmonary hypertension to other pulmonary disorders such as sleep apnea, sarcoidosis and other interstitial lung diseases.
Physicians
Sunil Sharma,
MD
West Virginia University
Positions
Division Chief, Professor, Division of Pulmonary/Critical Care & Sleep Medicine, Medicine
Appointed Program Medical Director, Respiratory Therapy